Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-25.32%
operating margin TTM
-21.11%
revenue TTM
398.99 Million
revenue per share TTM
3.18$
valuation ratios | |
|---|---|
| pe ratio | -11.40 |
| peg ratio | -0.53 |
| price to book ratio | 9.87 |
| price to sales ratio | 2.92 |
| enterprise value multiple | -14.41 |
| price fair value | 9.87 |
profitability ratios | |
|---|---|
| gross profit margin | 84.82% |
| operating profit margin | -21.11% |
| pretax profit margin | -25.18% |
| net profit margin | -25.32% |
| return on assets | -22.36% |
| return on equity | -79.42% |
| return on capital employed | -23.58% |
liquidity ratio | |
|---|---|
| current ratio | 4.25 |
| quick ratio | 3.81 |
| cash ratio | 2.22 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 250.49 |
| operating cycle | 377.42 |
| days of payables outstanding | 118.69 |
| cash conversion cycle | 258.73 |
| receivables turnover | 2.88 |
| payables turnover | 3.08 |
| inventory turnover | 1.46 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.53 |
| debt equity ratio | 2.06 |
| long term debt to capitalization | 0.66 |
| total debt to capitalization | 0.67 |
| interest coverage | -4.08 |
| cash flow to debt ratio | -0.19 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.71 |
| cash per share | 3.32 |
| operating cash flow per share | -0.71 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.19 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -218.03 |
Frequently Asked Questions
When was the last time Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) reported earnings?
Apellis Pharmaceuticals, Inc. (APLS) published its most recent earnings results on 05-11-2024.
What is Apellis Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)'s trailing twelve months ROE is -79.42%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Apellis Pharmaceuticals, Inc. (APLS) currently has a ROA of -22.36%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did APLS's net profit margin stand at?
APLS reported a profit margin of -25.32% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is APLS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.25 in the most recent quarter. The quick ratio stood at 3.81, with a Debt/Eq ratio of 2.06.